Cai Z - Search Results

1

Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program.

Du X, Jin J, Cai Z, Chen F, Zhou DB, Yu L, Ke X, Li X, Wu D, Meng F, DeMarco D, Zhang J, Mei J, Hou J. Du X, et al. Among authors: cai z. BMC Cancer. 2016 Jan 28;16:46. doi: 10.1186/s12885-016-2069-8. BMC Cancer. 2016. PMID: 26821931 Free PMC article. Clinical Trial.

2

[Studies on the correlation between production of L-malic acid and some cytosolic enzymes in the L-malic acid producing strain Aspergillus sp. N1-14].

Zhou X, Wu Q, Cai Z, Zhang J. Zhou X, et al. Among authors: cai z. Wei Sheng Wu Xue Bao. 2000 Oct;40(5):500-6. Wei Sheng Wu Xue Bao. 2000. PMID: 12548761 Chinese.

3

Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.

Zheng W, Wei G, Ye X, He J, Li L, Wu W, Shi J, Zhang J, Huang W, Xie W, Luo Y, Xue X, Lin M, Huang H, Cai Z. Zheng W, et al. Among authors: cai z. Leuk Res. 2009 Dec;33(12):1615-8. doi: 10.1016/j.leukres.2009.04.006. Leuk Res. 2009. PMID: 19773080

4

Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in China.

Lai YY, Huang XJ, Cai Z, Cao XS, Chen FP, Chen XQ, Chen BA, Fang MY, Feng JF, Fu WL, Guo HY, Hou M, Hou J, Hu Y, Hu XT, Hu XM, Huang LQ, Jin J, Li JY, Li J, Li W, Liang YM, Liu T, Liu QF, Liu YH, Mao P, Ouyang J, Qiu LG, Qiu L, Shao CK, Shi B, Song YP, Sun ZM, Wang QS, Wang C, Wang JM, Wang YS, Wang Z, Wu JB, Wu YX, Xia RX, Xue YQ, Yang BZ, Yang G, Yang ZL, Yu L, Yuan Z, Zhang S, Zhang Y, Zhao HG, Zhao L, Zhou DB, Zou SH, Zhu YF. Lai YY, et al. Among authors: cai z. Chin Med J (Engl). 2012 Aug;125(15):2663-70. Chin Med J (Engl). 2012. PMID: 22931972

5

[Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation].

Shi JM, Wang C, Zhou YH, Yu K, Du X, Luo Y, Cai Z, He JS, Ye XJ, Zhang J, Xie WZ, Huang H. Shi JM, et al. Among authors: cai z. Zhonghua Xue Ye Xue Za Zhi. 2013 May;34(5):413-6. doi: 10.3760/cma.j.issn.0253-2727.2013.05.008. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23688752 Clinical Trial. Chinese.

6

A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trial.

Hou J, Du X, Jin J, Cai Z, Chen F, Zhou DB, Yu L, Ke X, Li X, Wu D, Meng F, Ai H, Zhang J, Wortman-Vayn H, Chen N, Mei J, Wang J. Hou J, et al. Among authors: cai z. J Hematol Oncol. 2013 Jun 19;6:41. doi: 10.1186/1756-8722-6-41. J Hematol Oncol. 2013. PMID: 23782711 Free PMC article. Clinical Trial.

7

The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma.

He J, Yang L, Han X, Zheng G, Zheng W, Wei G, Wu W, Ye X, Shi J, Xie W, Li L, Zhang J, Huang W, Zhao Y, Huang H, Zhang X, Fu J, Cai Z. He J, et al. Among authors: cai z. PLoS One. 2014 Jun 11;9(6):e99174. doi: 10.1371/journal.pone.0099174. eCollection 2014. PLoS One. 2014. PMID: 24918626 Free PMC article.

8

Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment.

Zhou DB, Yu L, Du X, Jin J, Cai Z, Chen F, Ke X, Li X, Wu D, Meng F, Ai H, Zhang J, DeMarco D, Chen N, Mei J, Wang J, Hou J. Zhou DB, et al. Among authors: cai z. Int J Hematol. 2015 Jun;101(6):569-77. doi: 10.1007/s12185-015-1771-7. Epub 2015 Mar 10. Int J Hematol. 2015. PMID: 25753225 Clinical Trial.

9

Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study.

Wu D, Du X, Jin J, Xiao Z, Shen Z, Shao Z, Li X, Huang X, Liu T, Yu L, Li J, Chen B, He G, Cai Z, Liang H, Li J, Ruan C. Wu D, et al. Among authors: cai z. Adv Ther. 2015 Nov;32(11):1140-59. doi: 10.1007/s12325-015-0263-8. Epub 2015 Nov 14. Adv Ther. 2015. PMID: 26568466 Free PMC article. Clinical Trial.

10

Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia.

Hu Y, Wu Z, Luo Y, Shi J, Yu J, Pu C, Liang Z, Wei G, Cui Q, Sun J, Jiang J, Xie J, Tan Y, Ni W, Tu J, Wang J, Jin A, Zhang H, Cai Z, Xiao L, Huang H. Hu Y, et al. Among authors: cai z. Clin Cancer Res. 2017 Jul 1;23(13):3297-3306. doi: 10.1158/1078-0432.CCR-16-1799. Epub 2016 Dec 30. Clin Cancer Res. 2017. PMID: 28039267 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,544 results

Search Page